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A B S T R A C T
At a recent symposium on aging biology, a debate was held as to whether or not we know what biological aging
is. Most of the participants were struck not only by the lack of consensus on this core question, but also on many
basic tenets of the field. Accordingly, we undertook a systematic survey of our 71 participants on key questions
that were raised during the debate and symposium, eliciting 37 responses. The results confirmed the impression
from the symposium: there is marked disagreement on the most fundamental questions in the field, and little
consensus on anything other than the heterogeneous nature of aging processes. Areas of major disagreement
included what participants viewed as the essence of aging, when it begins, whether aging is programmed or not,
whether we currently have a good understanding of aging mechanisms, whether aging is or will be quantifiable,
whether aging will be treatable, and whether many non-aging species exist. These disagreements lay bare the
urgent need for a more unified and cross-disciplinary paradigm in the biology of aging that will clarify both areas
of agreement and disagreement, allowing research to proceed more efficiently. We suggest directions to en-
courage the emergence of such a paradigm.
1. Introduction
The authors were all participants at the Biology of Aging Symposium:
Understanding Aging to Better Intervene, held November 9–11, 2019 in
Montreal, Quebec. The symposium featured 44 speakers with a di-
versity of expertise related to aging, including basic aging biology,
translational geroscience, geriatric medicine, nutrition, im-
munosenescence, evolutionary ecology, demography, statistics, systems
biology, epidemiology, and complex systems theory. During the course
of the symposium, a debate was held on the question, “Do we know
what aging is?” with Brian Kennedy ostensibly arguing the “Yes” side
and Alan Cohen ostensibly arguing the “No” side. There was dynamic
audience participation. Most participants agreed that the debate and
the subsequent extensive discussion involving many participants were
striking in how they highlighted the lack of a clear consensus paradigm
(Kuhn, 1970) in the field, and collectively we agreed it would be im-
portant to describe this for the research community in our field.
Accordingly, we designed a survey that was sent to participants of
the symposium, both invited speakers and students/other participants.
The survey was meant to capture the opinions on both the key points of
disagreement and basic features of aging in general. All participants
who responded to the survey are co-authors. We use the term “aging” to
refer to “aging biology,” though, as will be shown, some but not all
participants felt that aging biology cannot be understood in isolation
from psychological, social, and cultural factors.
Philosophers of science generally believe that at least some aspects
of a shared paradigm or worldview are often critical in helping a field
advance, though the precise nature and role of such paradigms is de-
bated (Kuhn, 1970; Lakatos, 2014). Beyond the biology of aging that is
our focus here, it has been argued that there is a broad gerontological
paradigm spanning from biology to the social sciences (Ferraro, 2018),
with six key features: causality, life course analysis, multifaceted
change, heterogeneity, accumulation processes, and ageism. Our dis-
cussions at the symposium showed no consensus on questions relating
to ageism and causality, but generally supported the other four pro-
posed features. Nonetheless, the broad areas of disagreement shown
below will pose challenges for the field, and the nature of a paradigm is
likely to be quite different for aging biology than in gerontology more
broadly. If we cannot agree on what aging is (definitions and me-
chanisms), how can we identify it, measure it, or know if we are
measuring it (Belsky et al., 2015; Calimport et al., 2019; Horvath, 2013;
Levine, 2013)? How can we evaluate potential anti-aging interventions
(Justice et al., 2018)? How relevant are findings from other species in
terms of understanding human aging (Austad, 2010; Jones et al.,
2014)? We do not believe it is possible at this point to propose a
paradigm that would be broadly accepted in the field; accordingly, the
best we can do is to note the important differences and try to propose a




We used the tool Google Forms to distribute a survey to all parti-
cipants at the symposium (44 invited speakers, 2 organizers, 14 stu-
dents, and 11 others). The survey collected the following information:
(1) name; (2) demographic data (sex, country of origin, career stage)
(3) domains of expertise (multiple responses permitted); (4) Likert-scale
and other limited response questions (see below); and (5) a single open-
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ended question, “In no more than three sentences or 1000 characters,
please describe your understanding of what causes aging and what it is,
or is not, at a mechanistic level.”
The Likert scale used was, “For each of the following statements, do
you (1) Strongly disagree; (2) Moderately disagree; (3) Slightly dis-
agree; (4) Neutral; (5) Slightly agree; (6) Moderately agree; or (7)
Strongly agree?” The statements were:
1. We have a relatively good understanding of the basic biological
mechanisms of aging.
2. Some combination of the nine hallmarks (López-Otín et al., 2013)
or the seven pillars (Kennedy et al., 2014) does a relatively com-
prehensive job of describing the mechanisms of aging.
3. Aging proceeds uniformly across tissues.
4. It is or will soon be possible to have relatively reliable metrics of the
overall aging process
5. Aging cannot and should not be measured by a single metric be-
cause it is multi-dimensional and heterogeneous
6. It should be possible to quantify aging well even in the absence of a
clear consensus or mechanistic understanding of what aging is.
7. It should be possible to intervene in aging, and evaluate interven-
tions, even in the absence of a clear consensus or mechanistic un-
derstanding of what aging is.
8. There are many species across the tree of life that do not age at a
rate that is biologically relevant or appreciable
9. Broadly speaking, aging mechanisms are similar in most species
10. Mortality rates or survival curves are generally a reasonable proxy
for aging at the organismal level
11. It is important for the field to have a consensus definition of aging
12. Aging is an undesirable process that should be treated, cured, or
minimized
13. Aging biology can be understood largely as a cellular and molecular
process
14. Aging is genetically programmed and not just a by-product of im-
perfections or evolutionary constraints.
15. Aging will be reversible with the right technologies.
16. Anti-aging interventions have the potential to dramatically extend
human lifespan (beyond, say, 150 years).
Additional questions:
• Does aging begin approximately at (1) parental gamete formation;
(2) conception; (3) birth; (4) sexual maturity; or (5) later in life?
• Which of the following proposed anti-aging interventions are likely
to slow aging in humans with tolerable levels of side-effects (check
all that apply)? (1) senolytics/targeting senescent cells; (2) phar-
macological or gene editing control of known aging pathways
(metformin, rapamycin, NAD+, etc.); (3) enhancing cell replication
(e.g. telomerase activation such as via TA65); (4) direct attempts to
reduce macromolecular damage (e.g. proteasome activators such as
18aplha-GA, quercetin); (5) interventions in the immune system
(e.g. growth hormone to reverse thymic involution); (6) lifestyle
interventions; (7) other (list all that apply).
• What percent of what we observe as aging do you think can be at-
tributed to the following types of mechanisms (understanding that
they may coexist and interact with each other): [100 points that
should be distributed among the five options below]
o Damage accumulation (DNA damage, protein aggregates, struc-
tural damage, etc.)
o Maladaptation/antagonistic pleiotropy: mechanisms that are
useful early in life (e.g. for cancer prevention) become harmful
later in life.
o Adaptation: Adjustments the organism makes to either patholo-
gical aspects of aging or to changing needs (e.g. immune re-
pertoire) at different ages.
o Homeodynamic dysregulation: breakdown in the capacity of
complex regulatory networks to maintain homeodynamics
o Other [Up to 100 words to specify]
We obtained a waiver from the ethics committee at the CIUSSS-
ECHUS and post-hoc approval to conduct the survey (Project
#2021−3728).
2.2. Statistics
We provide only descriptive statistics and do not calculate standard
errors, confidence intervals, or p-values, which would only be relevant
Fig. 1. Profile of the survey respondents in terms of self-declared career stage (A) and expertise (B). For career stage, respondents chose one category. Two
respondents (post-bachelor’s and family doctor) volunteered responses not in the list. For expertise, each respondent checked as many boxes as they felt applied.
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if we could suppose that our sample was representative of a larger
population. We do not claim this to be the case, and prefer to present
only raw data. We did assess pairwise Pearson correlations among the
16 Likert-scale variables by transforming them to a 7-point scale, and
we also conducted exploratory principal components analysis (PCA) on
the covariance matrix of this dataset, though we present only the broad
strokes of those results due to fear that a 16-variable PCA with only 37
observations could be highly unstable. Analyses were conducted in R
version 3.5.2, using the “corrplot” package and the “princomp” func-
tion.
2.3. Limitations
Even though the questions were subject to substantial discussion
before the actual survey, with rewording performed throughout the
rounds of debate if necessary, some questions could be viewed as am-
biguous or be understood differently by some participants. In part, this
was due to different understanding of phrases such as “we understand,”
“damage," etc. We acknowledge these limitations, which we think do
not affect the core findings of this study.
3. Results
Thirty-seven researchers/students responded to the survey (the
authors of this paper). Demographically, 27 of 37 respondents were
male, with origins in 18 different countries. No country had more than
3 respondents except Canada, which had 14, though it is worth noting
that some respondents marked their current country of residence, some
marked their country of origin, some marked both, and some left the
field blank. Respondents were at a variety of career stages as early as
post-bachelor’s, but most (26) were established researchers/professors
(Fig. 1A). A variety of expertise was represented, with the great ma-
jority having at least some expertise in the basic biology of aging, and
many others with expertise in model organisms, metabolism, complex
systems theory, evolutionary ecology, etc. (Fig. 1B). Respondents were
also invited to volunteer additional expertise; these responses included:
Fig. 2. Responses to Likert-scale questions on aging, ordered from top to bottom by decreasing consensus.
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“Neuroscience and computer modelling,” “Neurodegenerative disease,”
“Biodemography of aging, health, and longevity,” “Bioinformatics,” and
“Cell signalling, cell death, degenerative diseases, microenvironment.”
While our respondents do not represent a random sample of aging re-
searchers, they do represent a wide variety of expertise in the field, and
most are far enough advanced in their studies to have well-informed
opinions on aging biology. Sample size was insufficient to formally
compare responses by subgroups, but an informal analysis by sex sug-
gests there are no particularly marked differences in opinions between
male and female researchers.
Most of the key questions were asked on a 7-level Likert scale, and
responses are summarized in Fig. 2. Of 16 questions, 11 had at least one
respondent in each of the most extreme categories (“Strongly agree”
and “Strongly disagree”), and all 16 had responses ranging from
Strongly on one end to Moderately on the other. For three questions,
there was nonetheless a clear preponderance of respondents taking one
opinion. For whether aging proceeds uniformly across tissues, 86 %
disagreed (strongly, moderately, or slightly). Regarding the multi-di-
mensionality of aging, 86 % agreed strongly, moderately, or slightly
that it is heterogeneous and cannot be measured with a single metric.
Most respondents (81 %) agreed strongly, moderately, or slightly that it
is important for the field to have a consensus definition of aging. For
four other questions, there was a clear tendency in one direction even if
there was still substantial disagreement: more respondents than not
concurred that aging is largely a cellular/molecular process (75 %), that
the hallmarks/pillars (Kennedy et al., 2014; López-Otín et al., 2013) do
a decent job of summarizing the aging process (72 %), that mortality
rates are a reasonable proxy for organismal aging (72 %), and that
aging is undesirable (69 %). In other words, for 9 out of 16 questions,
there is no clear trend for a consensus of opinion (< 65 % on one side or
the other), and diametrically opposed views were held by comparable
numbers of researchers among our relatively small sample. Even for the
two questions with the most agreement, it is worth noting that among
the three researchers in the opposing camp in each case, two were
among the best-known experts in the field (h-index>100).
Unsurprisingly, there appeared to be a clear correlation structure
among the Likert-scale questions (Fig. 3), though in many cases the
limited sample size makes precise estimation of the coefficients
doubtful. Broadly, those who thought aging should be cured/treated
also tended to think it was more likely for this to be possible, and that
aging was readily quantifiable, programmed, and universal. PCA con-
firmed this: 34 % of the variance was explained by the first axis, and 15
% by the second, with the loadings of the first axis qualitatively re-
flecting the summary of the correlation matrix. While the correlation
structure is clear, it is not overwhelmingly strong, indicating that there
are not simply two opposing camps with a range of opposing views.
As for when aging begins, there was also marked disagreement, with
a relatively uniform distribution of responses ranging from parental
gamete formation to later in life (Fig. 4A). One participant has argued
recently that the answer is none of the above: that aging begins very
early in life (during embryogenesis), but the exact moment is not de-
fined (Kinzina et al., 2019). For interventions likely to slow aging, there
was near-consensus on some potential interventions but not others
(Fig. 4B). Only 2 of 35 respondents thought enhancing cell replication
was promising, and 91 % (32/35) thought lifestyle interventions were
promising, but for the other four interventions, between 29 % and 63 %
thought them promising, showing substantial divergence in opinions of
researchers. Furthermore, this was not due to a small set that found all
interventions promising and a larger set that found none or only life-
style promising; there was a relatively uniform distribution of how
many interventions were thought promising (Fig. 4C). Some re-
spondents noted additional interventions they thought promising:
“Healthy, diversified nutrition, in particular digital tool aided perso-
nalized nutrition,” “Minimize somatotroph dysfunction,” “Combination
of pharmacological (including those affecting immune function) and
lifestyle,” and “Prevention of early changes in the organism (disease-
dependent etc).”
Lastly, there was substantial heterogeneity in how respondents saw
the mechanisms of aging (Fig. 4D). Damage accumulation was perhaps
seen as slightly more important than the others on average, con-
tributing from 5 % to 60 % with a median of 30 %. Next was home-
odynamic dysregulation, contributing from 0 % to 70 % with a median
of 25 %. Maladaptation and adaptation both had means of 20 %, though
maladaptation had a larger range (0 %–70 %) than adaptation (5 %–50
%). Some respondents indicated additional classes of mechanisms, with
the following texts and percentages: “This will be different for each
individual depending on genetic and environmental exposition. Perso-
nalized medicine will help.”; “The intrinsic (causal) interactions be-
tween the abovementioned mechanisms makes it artificial to rate them
separately”; “Pre-programmed cellular death and aging orchestrated by
genetics/epigenetics (40 %)”; and “reserve depletion (20 %); slowdown
in metabolism and information processing (20 %).”
In addition to this summary of the survey results, we provide the
results on a website, http://survey.cohenlab.ca/, that will allow other
members of the field to fill out the survey, and allows users to visualize
and download data by different subsets of respondents (established
researchers, domains of expertise, etc.). If many of our colleagues and
readers fill out the same survey, we may increase both the sample size
and potentially the representativity.
3.1. Definitions of aging
Responses to the question “In no more than three sentences or 1000
characters, please describe your understanding of what causes aging
and what it is, or is not, at a mechanistic level” were highly diverse.
Some representative examples of this diversity are shown in Table 1,
and the full list of definitions can be found in Supplement 1. Note that
some definitions refer explicitly to programs, and others are explicitly
non-programmed. Some are primarily focused on damage, others on
system dynamics. Some refer to cellular mechanisms, others to systemic
or organism-level mechanisms. Some definitions suggest that aging rate
is modified by the environment, others that it is not. Some situate aging
explicitly in an evolutionary context, others focus exclusively on cel-
lular/biochemical mechanisms. While not all these contrasts are mu-
tually exclusive, they represent a remarkable diversity of perspectives.
Fig. 3. Correlation matrix representing Pearson correlation coefficients be-
tween the 16 Likert-scale questions. Correlations that were not significant at α
= 0.05 are left blank above the diagonal. Numbers on the diagonal refer to the
question numbers in the main text.
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4. Discussion
The results of our survey undeniably confirm the impression at the
symposium: there is no clear consensus in the field of aging biology,
even on the most fundamental questions. There was a near-consensus
(but not complete) that aging is heterogeneous, reflected in a clear
preponderance of respondents considering that aging does not proceed
uniformly across tissues and that aging cannot be measured with a
single, unidimensional metric. The only other question with such a
clear preponderance of support was on the need for the consensus,
which we have demonstrated here does not currently exist.
Some degree of disagreement in a scientific discipline is expected –
it would be surprising to find complete consensus, particularly on
questions under active investigation. Nonetheless, we argue that the
disagreement is striking for the types of questions we posed, at least for
many of them. For example, there was major disagreement as to whe-
ther we have a good understanding of the basic biological mechanisms
of aging, whether it will soon be possible to reliably measure aging,
whether there are many species that do not age appreciably, whether
aging mechanisms are similar across species, whether aging is largely a
cellular and molecular process, and whether aging is genetically pro-
grammed, among others. Given our relatively detailed knowledge of
molecular pathways related to aging (Pan and Finkel, 2017), this level
of disagreement among well renowned, established researchers/pro-
fessors on such larger questions should perhaps be of major concern to
the field.
We note an important caveat on the apparent disagreement we
show: it was nearly impossible to formulate questions to be uniformly
understood so as to elicit perfectly clear responses, and the wording of
the questions was subject to substantial discussion before the final
survey was circulated. For example, a participant’s definition/concep-
tion of aging likely influenced responses to downstream questions.
Perhaps the clearest example of this is when aging begins: if aging is
largely damage accumulation, it likely begins before birth (Kinzina
et al., 2019), but if it is based on mortality/reproduction patterns or
maladaptation/antagonistic pleiotropy (mechanisms that are useful
early in life become harmful later in life), it begins closer to sexual
maturity or later in life (Gaillard and Lemaître, 2017; Williams, 1957).
Another example would be a statement like “We have a good under-
standing of X.” Who is “we,” the researcher or the field? How good is
Fig. 4. Responses to non-Likert questions. (A) Counts (absolute number) of answers to when aging starts. (B) Counts (absolute number) of respondents endorsing
intervention classes thought likely to slow aging. (C) Counts (absolute number) of respondents endorsing intervention classes thought likely to slow aging (D)
Relative contribution (%) of different classes of mechanisms to the aging process.
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good? What do we mean by understanding? In this sense, the apparent
disagreements in responses to our questions may thus be somewhat
exaggerated. Nonetheless, our questions were formulated in ways that
are typical of discussions in the field, and at the very least the dis-
agreement we show indicates that we have major communication issues
to overcome. For example, it is common to read that aging is reversible
(López-León and Goya, 2017) (and 42 % of our respondents felt so to
differing degrees), but what do we mean by aging? Mortality rates, or
biomarker signatures? Which biomarkers? What exactly is reversible,
and to what extent? Likewise, if we ask whether aging proceeds uni-
formly across tissues (86 % of us felt it doesn’t), the answer might be
different if we are considering indicators of conserved genetic pathways
versus epigenetic signals versus tissue functionality.
Despite this caveat, many disagreements are clearly about facts/
reality rather than definitions. For example, disagreement as to whether
aging is programmed or not might be slightly attributable to commu-
nication, but, based on the definitions, also clearly reflects real differ-
ences of opinion. Our objective here is not to settle these differences or
to take a side, but simply to point them out.
The definitions of aging are particularly enlightening and often
explicitly showed the differences in opinions reflected in the guided
questions. Answers ranged from mechanistic to evolutionary, with
answers sometimes referring explicitly to either a presence or absence
of programming (Blagosklonny, 2013; Goldsmith, 2012; Kowald and
Kirkwood, 2016). Some respondents thought the basis is fundamentally
cellular and molecular, whereas others saw important roles for higher-
order processes, or defined aging around functionality and phenotype
rather than underlying processes. While these ideas are not necessarily
mutually exclusive, the combination of the survey questions and the
definitions indicate substantial disagreement as to whether an under-
standing of aging biology should include mechanisms beyond cellular/
molecular biology. Certain notions were repeatedly referenced, notably
damage accumulation (e.g. via imperfect repair mechanisms)
(Gladyshev, 2014) and loss of homeostasis (Cohen, 2016), reflecting
areas of active interest among many researchers. This highlights that
while there is immense disagreement at some levels, certain subsets of
researchers are also actively converging on similar ideas, even if these
ideas may not be shared by all. The lack of consensus is thus not a
complete absence of convergence or coherence.
What should we do as a research community, in the face of this
disagreement? We hope that simply becoming aware of the problem
may stimulate researchers to consider aging in new ways, and to in-
teract with colleagues that may have a different perspective. Beyond
that, we suggest three complementary approaches that may help. First,
though basic biologists tend to avoid theory, we think it is important for
the field to develop an explicit theoretical paradigm. Of course there
will be some disagreement, but this should largely occur within areas of
the paradigm that are still unclear. This paradigm should include an
attempt to link a variety of sub-disciplines, encompassing mechanistic,
evolutionary, and demographic approaches to aging (e.g. 22). It should
also link the conserved signalling pathways and the downstream me-
chanisms, and should integrate comparative, epidemiological, and
clinical perspectives. Any understanding of aging cannot be considered
complete if it fails to explain or disagrees with a major sub-discipline.
For example, our understanding of the mechanistic basis of aging
should complement and clarify our understanding of how lifespan
evolves across evolutionary time in response to selection pressure, and
vice-versa. It should thus be possible to construct an interdisciplinary
understanding of aging progressively merging mechanistic and evolu-
tionary aspects (Cui et al., 2019; MacRae et al., 2015). This may require
the application of approaches to clearly define the questions, dis-
agreements, and terminological confusion. Much as the Hallmarks/
Pillars of Aging unified what was before a relatively fragmented land-
scape of mechanistic research of aging (Kennedy et al., 2014; López-
Otín et al., 2013), a similar effort is probably required to unify into a
single paradigm mechanistic approaches, research on conserved reg-
ulatory pathways, epidemiology, evolutionary biology, clinical ger-
iatrics, late-life diseases, and so forth (Fig. 5).
Accordingly, the second approach is to bridge some of the gaps
between our sub-disciplines, not just with theory, but with concrete
collaborations. While there is certainly some movement of information
across the sub-disciplines, there are major questions that are not being
sufficiently tackled. How might a mechanistic understanding of aging
impact clinical geriatrics? What can species differences in aging me-
chanisms tell us about the evolution of life history strategies? Beyond
the construction of a paradigm, there is a need to conduct research at
the interface of sub-disciplines of aging. This would present an oppor-
tunity to benefit from the productivity and effectiveness of what has
been called the multidisciplinary edge effect (Varpio and MacLeod, 2019):
In ecology, the edge effect refers to characteristics observed when the
boundaries of two different habitats meet (e.g., when forests meet rocky
outcrops). When the edges of ecosystems intersect, a greater biodi-
versity exists. Likewise, in research on aging biology, we might expect
the most productive research questions to exist at the frontiers between
our subdisciplines. These two efforts, theoretical and empirical, should
nourish each other. Third and complementary, training of young re-
searchers in aging biology should explicitly involve exposure to this
multidisciplinary context, with courses and discussions designed to
Table 1
Examples of the diverse mechanistic definitions of aging.
“We do not know what causes aging. I think the trigger is endogenous but not
necessarily programmed.” (G. Ferbeyre)
“Aging is mainly accumulation of macromolecular damage and failure of adaptation
to a continuous changing environment. It is also an epiphenomenon of the
outcome of the protective conditions we humans have achieved thanks to
civilization over time and to this end somehow it doesn't comply fully with
typical Darwinian Biology.” (E.S. Gonos)
“As an evolutionary biologist, I see 'aging' as the decrease in the age-specific
contribution to fitness. […] At a mechanistic level, aging (or I should say
'senescence') corresponds to any deterioration of cellular/physiological traits that
will ultimately impact fitness.” (J.F. Lemaître)
“Mechanistically, aging is a disruption of the homeostasis established between
cellular processes. Age-related-diseases are the external symptoms of this
disruption. […] Aging is the result of [an] imperfect optimization to maintain a
balance between evolutionary constraints, cellular dynamical equilibrium and
environmental constraints. […] Aging is not a programmed process but a
consequence of this search for an equilibrium.” (Q. Vanhaelen)
“Time-dependent degradation of interactions or their (quasi)adaptative changes;
sluggish and/or ineffective responses to challenges; when more than one such
response is biologically relevant, aging would manifest as preference for a
response different than one preferred at youth. The latter response may still be
effective, but at higher cost for an aging organism (e.g. increased innate,
inflammatory responses to pathogens in the old).” (J.M. Witkowski)
“Aging is the progressive decline of function with increasing chronological age due to
internal factors that are not dependent on environment, which leads to an
increased probability of death. Aging is caused by a genetically programmed
switch that downregulates cellular pathways involved in homeostasis, stress
response, repair etc. that evolved to limit competition for resources between
offspring and parent.” (J. Van Raamsdonk)
“I believe that some mechanism that clears damage from the germline (which is
immortal) is toxic to the rest of the organism. This toxicity interferes with
transcription at the DNA or protein level, leading to imbalanced proteostasis.
Chromatin condensation therefore becomes abnormal (as measured by
epigenetic clocks) which disrupts function of the organism as a whole and likely
exponentially through a negative feedback loop.” (T. Liontis)
“Ageing is caused by a breakdown in repair mechanisms due to a shift of resource
allocation after reproduction, modulated according to the environmental niche of
the organism.” (G. Pawelec)
“Aging is not programmed. Aging is the result of complex interactions between the
genome and physiological and environmental changes, with feedback loops that
lead to physical and mental impairment. Organisms are not adapted to naturally
live indefinitely.” (F. Dufour)
“Repair machineries fail to keep up with internal and external damage; systems
become dysregulated and eventually collapse.” (V. Gorbunova)
“The gradual break-down of cellular components, leading to the eventual death of the
organism, associated with time. This is caused by DNA damage, mutations,
genetic/epigenetic pre-programmed senescence, protein aggregates and
environmental stress.” (U. Anglas)
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ensure that students are exposed to a wide range of mechanistic, ge-
netic, evolutionary, ecological, clinical, and epidemiological perspec-
tives.
What might an emerging paradigm look like? Ideally, it would
provide a framework that largely integrates the basic knowledge from
these varied domains, identifying key areas of consensus, as well as
areas of continued disagreement. It would provide a coherent structure
for terminology, and indeed perhaps a more precise vocabulary for
words that are used in different ways in different sub-disciplines – in-
cluding the word “aging” itself (Cohen et al., 2020; Gladyshev, 2016) –
might go a long way toward creating this framework. As needed, it
would include a mathematical framework to ensure appropriate rigor.
We are not under any illusion that this will be an easy task.
Disagreement on, say, the programmed vs. non-programmed nature of
aging is unlikely to be resolved soon, and without consensus on such
points it becomes difficult to also have consensus on broader questions
such as how to integrate an evolutionary and mechanistic under-
standing of aging. However, we also argue that cross-talk between sub-
disciplines will gradually clarify the points of disagreement and even-
tually lead to a more effective and valuable paradigm on aging biology.
If such a paradigm does not emerge organically over the next several
years, it may be worth considering organizing a more formal con-
sultation process with key experts from various subdisciplines in order
to generate a consensus framework.
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Fig. 5. A conceptual model of how our understanding of aging biology will
need to integrate perspectives from diverse disciplines. The precise definition of
disciplines is somewhat arbitrary.
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